Drug Trial Radar · NCT07793513
Study of BK1803 in Healthy Infants
Last checked: Nov 19, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
344
Planned (sponsor's estimate)
Start
Oct 21, 2026
Primary completion
Apr 2029
Study completion Apr 2029
Sponsor
- Lead sponsor
- Tanabe Pharma CorporationIndustry
- Sponsor type
- Industry
- Collaborators
- The Research Foundation for Microbial Diseases of Osaka University (BIKEN)
- First posted
- Aug 28, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Prevention
- FDA-regulated drug
- No
- Who can join
- All sexes, from 2 months, up to 6 months
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This study is a phase 3, randomized, observer-blinded, active-controlled, multicenter study to evaluate the immunogenicity and safety of BK1803 in healthy infants aged 2 months to less than 7 months. Participants will be randomized to receive either BK1803 or a control regimen consisting of GOBIK Aqueous Suspension Syringes and Bimmugen® Injection. The primary objective is to demonstrate the noninferiority of BK1803 compared with the control in terms of antibody seroprotection rates against hepatitis B surface (HBs) antigen, Haemophilus influenzae type b (Hib), pertussis, diphtheria, tetanus, and poliovirus. Safety will also be assessed throughout the study.
Conditions
- Pertussis
- Diphtheria
- Tetanus
- Poliomyelitis
- Hepatitis B
- Haemophilus Influenzae Type b
Interventions
BK1803Biological
BK1803 is a combination vaccine administered intramuscularly according to the study vaccination schedule, including primary and booster immunizations.
GOBIK Aqueous Suspension SyringesBiological
GOBIK Aqueous Suspension Syringes is a combination vaccine administered intramuscularly according to the study vaccination schedule.
Bimmugen® InjectionBiological
Bimmugen® Injection is a hepatitis B vaccine administered subcutaneously according to the study vaccination schedule.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Antibody seroprotection rates against vaccine antigens in the BK1803 of Main CohortTime frame: 4 weeks from the post-primary immunization of BK1803 in Main Cohort (Visit4)
- Antibody seroprotection rates against vaccine antigens for HBs antigen in the Control of Main CohortTime frame: 4 weeks from the post-booster immunization of Bimmugen in Main Cohort (Visit6)
- The antibody seroprotection rates against vaccine antigens for PRP, PT and FHA, diphtheria toxin, tetanus toxin, and attenuated poliovirus in the Control of Main CohortTime frame: 4 weeks from the post-primary immunization of GOBIK in Main Cohort (Visit4)
Locations
33 sites in 1 country. Site status is shown where the registry gives one.
Fukui Aiiku Hospital
Fukui-shi, Fukui, Japan · Recruiting
Oda Children's Allergy Clinic
Fukuoka, Fukuoka, Japan · Recruiting
Morooka Chirdren's Chikushi-dori Clinic
Fukuoka, Fukuoka, Japan · Recruiting
Shindo children's clinic
Fukuoka, Fukuoka, Japan · Recruiting
Kurokawa Michiko Pediatric Clinic
Fukuoka, Fukuoka, Japan · Recruiting
Japanese Red Cross Fukuoka Hospital
Fukuoka, Fukuoka, Japan · Recruiting
Isesaki Municipal Hospital
Isesaki, Gunma, Japan · Recruiting
Japanese Red Cross Maebashi Hospital
Maebashi, Gunma, Japan · Recruiting
Yoshimitsu Pediatric Clinic
Hiroshima, Hiroshima, Japan · Recruiting
Taniguchi Children Clinic
Hiroshima, Hiroshima, Japan · Recruiting
Ishikari Kids Clinic
Ishikari-shi, Hokkaido, Japan · Recruiting
Hibarigaoka Kodomo Clinic
Sapporo, Hokkaido, Japan · Recruiting
Araki Children Clinic
Sapporo, Hokkaido, Japan · Recruiting
Japan Community Healthcare Organization Hokkaido Hospital
Sapporo, Hokkaido, Japan · Recruiting
Kumagai Children's Clinic
Amagasaki, Hyōgo, Japan · Recruiting
Hamami Kodomo Clinic
Chigasaki, Kanagawa, Japan · Recruiting
Kawasaki Municipal Hospital
Kawasaki-shi, Kanagawa, Japan · Recruiting
Sagamihara Kyodo Hospital
Sagamihara, Kanagawa, Japan · Recruiting
Kochi Health Sciences Center
Kochi, Kochi, Japan · Recruiting
Sakuranbo Kodomo Clinic
Kumamoto, Kumamoto, Japan · Recruiting
Ina Central Hospital
Ina-shi, Nagano, Japan · Recruiting
JISENKAI Healthcare Incorporated Foundation, Aizawa Hospital
Matsumoto, Nagano, Japan · Recruiting
Arakawa Family Clinic
Nagano, Nagano, Japan · Recruiting
Asama General Hospital
Saku, Nagano, Japan · Recruiting
Nara Prefecture General Medical Center
Nara, Nara, Japan · Recruiting
Aizenbashi Hospital
Osaka, Osaka, Japan · Recruiting
Aiwa Hospital
Kawagoe-shi, Saitama, Japan · Recruiting
Hara Children's Clinic
Tokorozawa, Saitama, Japan · Recruiting
Yaizu City Hospital
Yaizu, Shizuoka, Japan · Recruiting
Medical Corporation Asbo Tokyo Asbo Clinic
Chuo-ku, Tokyo, Japan · Recruiting
Aquakids Clinic
Edogawa-Ku, Tokyo, Japan · Recruiting
Okawa Children & Family Clinic
Ōta-ku, Tokyo, Japan · Recruiting
Karugamo Clinic
Setagaya-Ku, Tokyo, Japan · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.